Bressman S, Fahn S, Eisenberg M, Brin M, Maltese W
Adv Neurol. 1986;43:119-25.
Prominent neurological abnormalities, including myoclonus, seizures, ataxia, and hearing loss, have been noted in juvenile-onset biotin-responsive MCD. The underlying defect in many of these patients, who generally present in the first year of life, appears to be a deficiency of biotinidase. We have presented a young woman with adult-onset myoclonus, ataxia, hearing loss, seizures, hemianopia, and hemiparesis who responded to pharmacologic dosages of biotin. Although she displayed many of the clinical and biochemical features of juvenile-onset MCD, she did not have a biotinidase deficiency, and the underlying defect remains to be determined. Because of her response to biotin, we have advocated that other patients with unexplained myoclonus syndromes be evaluated for biotin-dependent carboxylase deficiencies and undergo a therapeutic trial with biotin.
在青少年起病的生物素反应性MCD中,已注意到显著的神经学异常,包括肌阵挛、癫痫发作、共济失调和听力丧失。这些患者大多在出生后第一年发病,其潜在缺陷似乎是生物素酶缺乏。我们报告了一名成年起病的年轻女性,她有肌阵挛、共济失调、听力丧失、癫痫发作、偏盲和偏瘫,对生物素的药理剂量有反应。尽管她表现出许多青少年起病的MCD的临床和生化特征,但她没有生物素酶缺乏,潜在缺陷仍有待确定。由于她对生物素的反应,我们主张对其他不明原因的肌阵挛综合征患者进行生物素依赖性羧化酶缺乏评估,并进行生物素治疗试验。